A superior, next generation
transgenic platform

Tailored licensing options

Ablexis Announces Multi-Target
Licensing Agreement with Zai Lab (US)

About

The industry's leading transgenic platform.

MORE
Technology

For efficient discovery and development of antibody and antibody-derivative drug candidates.

MORE
Licensing

Our license options are designed to meet the needs of our partners.

MORE
News & Events

Ablexis Announces Multi-Target Licensing Agreement with Zai Lab (US)

MORE